This UnitedHealth Group Analyst Turns Bearish; Here Are Top 3 Downgrades For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Compass Point analyst Casey Alexander downgraded the rating for PennantPark Investment Corporation PNNT from Neutral to Sell and lowered the price target from $6 to $5.75. Pennant Park Investment shares closed at $6.91 on Tuesday. See how other analysts view this stock.
• HSBC analyst Sidharth Sahoo downgraded UnitedHealth Group Incorporated UNH from Hold to Reduce and lowered the price target from $490 to $270. UnitedHealth shares closed at $321.58 on Tuesday. See how other analysts view this stock.
• Scotiabank analyst Sung Ji Nam downgraded the rating for Myriad Genetics, Inc. MYGN from Sector Outperform to Sector Perform and cut the price target from $20 to $6. Myriad Genetics shares closed at $4.45 on Tuesday. See how other analysts view this stock.

Considering buying UNH stock? Here’s what analysts think:

Get Started

Earn 7.2% — No Matter What the Fed Does

Markets expect rate cuts — but your earnings don’t have to suffer. Lock in 7.2% until 2028 from ten individual bonds.

Get Started

Read This Next:

• Target, Lowe’s And 3 Stocks To Watch Heading Into Wednesday

Photo via Shutterstock